BTAI Reports $206K Revenue, $12.7M Net Loss in Q1 2026
BioXcel Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.19
+15% in 7d after detection
Post-detection moves
1h
—
1d
-0.9%
3d
-4.4%
7d
+15%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS